Table 1: Clinical Data (N = 60)
| Water (%) | Spore (%) | Placebo (%) | Total (%) | P | |
| Enrolled Patients (N) | 20 | 20 | 20 | ||
| Mean Age (Range; Years) | 54.40 (27-75) | 54.90 (40-64) | 56.20 (46-72) | 0.76 | |
| Mean Body Surface Area (m2) | 1.51 (1.18-1.79) | 1.42 (1.22-1.76) | 1.48 (1.29-1.83) | 0.16 | |
| Malignancy Diagnosis Ovary Corpus Cervix PPA Fallopian Tube Choriocarcinoma Vagina |
15 (34.1) 3 (60.0) 1 (33.3) - 1 - - |
16 (36.4) 2 (40.0) - - - 1 1 |
13 (29.5) - 2 (66.7) 2 3 - - |
44 (73.3) 5 (8.3) 3 (5.0) 2 (3.3) 4 (6.7) 1 (1.7) 1 (1.7) |
0.11 |
| Previous Surgery | 19 (95.0) | 19 (95.0) | 19 (95.0) | 57 (95.0) | 1.00 |
| Previous Radiation | 6 (30.0) | 2 (10.0) | 2 (10.0) | 10 (16.7) | 0.19 |
| Underlying Disease | 7 (35.0) | 7 (36.8) | 6 (30.0) | 20 (33.9) | 0.89 |
| Previous Chemotherapy (Mean; range)n | 3.25 (2-7) | 4.20(2-7) | 3.30 (2-6) | 0.06 | |
| Withdrawn Patients | 9 (45.0) | 12 (60.0) | 11(55.0) | 32 (53.3) | 0.72 |